Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
LIC MF Healthcare Fund (G) Direct |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.37 |
Equity |
96.07 |
Trep |
4.30 |
|
|
Concentration Analysis |
Top 5 Holdings |
44.21% |
Top 10 Holdings |
70.62% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
74.38 |
Healthcare |
21.69 |
Cash |
3.93 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.86 |
PE Ratio |
37.45 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
14.54 |
Apollo Hospitals Enterprise Limited |
8.37 |
Dr Reddys Laboratories Limited |
8.16 |
J B Chemicals and Pharma Ltd |
6.78 |
Cipla Limited |
6.36 |
DIVI LABORATORIES LTD |
5.82 |
Zydus Lifesciences Limited |
5.45 |
Piramal Pharma Limited |
5.44 |
Torrent Pharmaceuticals Limited |
4.94 |
Abbott India Limited |
4.76 |
Alkem Laboratories Limited |
4.41 |
IPCA Laboratories Limited |
4.36 |
Tri Party Repo |
4.30 |
Global Health Limited |
3.76 |
Metropolis Healthcare Limited |
3.74 |
Laurus Labs Limited |
3.36 |
Syngene International Limited |
3.21 |
Artemis Medicare Services Limited |
2.61 |
Net Current Assets |
-0.02 |
Net Receivables / (Payables) |
-0.35 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|